What are the drug interactions of duloxetine (Cymbalta) with commonly used medications?

Duloxetine Drug Interactions with Commonly Used Medications

Duloxetine has clinically significant interactions primarily through CYP1A2 inhibition (which increases duloxetine levels dramatically) and through its own moderate CYP2D6 inhibition (which increases levels of drugs metabolized by this pathway). 1

Critical Contraindications and Dangerous Interactions

MAOIs - Absolute Contraindication

• Do not combine duloxetine with MAOIs intended to treat depression - this is contraindicated due to risk of serotonin syndrome 1
• Allow appropriate washout periods between switching medications

Thioridazine - Do Not Combine

• Duloxetine should not be co-administered with thioridazine due to risk of serious ventricular arrhythmias and sudden death from elevated thioridazine plasma levels 1

Alcohol - Avoid Combination

• Do not prescribe duloxetine to patients with substantial alcohol use - the combination may cause severe liver injury 1

Major Drug Interactions Requiring Dose Adjustments or Avoidance

CYP1A2 Inhibitors - Avoid or Use Extreme Caution

Potent CYP1A2 inhibitors should be avoided with duloxetine 1, 2. When fluvoxamine (a potent CYP1A2 inhibitor) was co-administered with duloxetine, the area under the curve increased by 460% and peak concentration increased by 141% 2. This represents the most clinically significant pharmacokinetic interaction with duloxetine.

Other CYP1A2 inhibitors to avoid or use cautiously:

• Fluvoxamine (most potent - avoid)
• Ciprofloxacin
• Enoxacin

Note: Smoking decreases duloxetine concentration by approximately 30%, so smokers who quit may experience increased duloxetine effects 2

CYP2D6 Substrates - Monitor Closely

Duloxetine is a moderate CYP2D6 inhibitor and will increase plasma concentrations of drugs metabolized by this pathway 1, 3. Exercise particular caution with narrow therapeutic index drugs:

• Tricyclic antidepressants (nortriptyline, amitriptyline, imipramine) - monitor TCA plasma concentrations and reduce TCA dose if needed 1
• Type 1C antiarrhythmics (propafenone, flecainide) - approach with caution 1
• Phenothiazines - use cautiously 1

However, recent evidence suggests the clinical impact may be less than feared. A study found duloxetine did not significantly increase concentrations of risperidone or aripiprazole (both CYP2D6 substrates), suggesting duloxetine may be safely used with these antipsychotics 4. Similarly, a 2024 study showed duloxetine increased citalopram exposure 4-fold, but this was primarily through CYP2D6 and P-glycoprotein inhibition 5.

Moderate Interactions Requiring Monitoring

Serotonergic Drugs - Monitor for Serotonin Syndrome

When combining duloxetine with other serotonergic medications, carefully monitor for serotonin syndrome 1. This includes:

• Triptans - if clinically warranted, observe carefully especially during initiation and dose increases 1
• SSRIs/SNRIs - increased risk when combining 5
• Tryptophan and other serotonin precursors - not recommended 1
• Certain analgesics with serotonergic properties 6

Signs of serotonin syndrome include: mental status changes, autonomic instability, neuromuscular aberrations, and GI symptoms 1

Anticoagulants and Antiplatelet Agents - Bleeding Risk

Duloxetine increases bleeding risk when combined with NSAIDs, aspirin, warfarin, or other anticoagulants 1. However, a large observational study found no evidence of increased upper GI bleeding risk when duloxetine was combined with prescription NSAIDs or aspirin 7. Despite this reassuring data, the FDA label recommends cautioning patients about this potential risk 1.

Drugs Causing Orthostatic Hypotension

Risk of blood pressure decreases is greater when duloxetine is combined with:

• Antihypertensive medications
• Other drugs inducing orthostatic hypotension 1

Monitor blood pressure, especially during initiation and dose increases 1.

Interactions with Minimal Clinical Impact

CYP2D6 Inhibitors

While CYP2D6 inhibitors increase duloxetine exposure by approximately 60%, this does not typically require dose adjustment due to duloxetine's wide therapeutic margin 1, 2. CYP2D6 poor metabolizers similarly have increased exposure but generally tolerate duloxetine without dose modification 2.

Gastric pH Modifiers

Histamine H2-receptor antagonists and antacids do not impact duloxetine absorption 2

Benzodiazepines

Duloxetine may enhance benzodiazepine effects, but this interaction is generally manageable with monitoring 2

Warfarin

Pharmacodynamic studies show duloxetine does not significantly affect warfarin's anticoagulant effects 2

Key Clinical Pearls

• The most dangerous interaction is with potent CYP1A2 inhibitors (especially fluvoxamine), which can increase duloxetine levels nearly 5-fold 2
• Duloxetine's CYP2D6 inhibition is moderate - clinically significant primarily for narrow therapeutic index drugs 3
• Hepatic and renal function matter more than most drug interactions - avoid in hepatic impairment and severe renal impairment 2
• Age, sex, and smoking status influence duloxetine levels independent of drug interactions 2, 8
• Recent evidence suggests duloxetine's interaction profile may be more forgiving in practice than theoretical concerns suggest 4, 7